MedTrace Logo

A Safety and Efficacy Study of the Birmingham Hip Resurfacing System

NCT00611585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 329

Last updated 2026-04-15

No results posted yet for this study

Summary

The purpose of this study is to meet a PMA condition of approval of the BHR System. The study will evaluate the long term safety and effectiveness of the BHR system in patients with non-inflammatory and inflammatory arthritis.

Conditions

Interventions

DEVICE

Birmingham Hip Resurfacing

Hip resurfacing system: single use device for hybrid fixation in patients requiring primary hip resurfacing arthroplasty

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Andy Engh, MD · Anderson Orthopaedic Clinic

  • Lawrence Housman, MD · Tucson Orthopaedic Institute

  • John Masonis, MD · OrthoCarolina Research Institute, Inc.

  • Edwin Su, MD · Hospital for Special Surgery, New York

  • John Noble, Jr., MD · Center for Orthopaedics

  • Michael Anderson, MD · Aurora Medical Center

  • Christopher Drinkwater, MD · University of Rochester

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-06
Primary Completion
2025-05-12
Completion
2025-05-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611585 on ClinicalTrials.gov